Intiva Biopharma Inc., of Glendale, Colo., has filed to sell 2.46 million shares of common stock. According to its filing, it is developing drugs containing cannabinoids and/or terpenes for the treatment of various diseases. The company's shares trade on the OTCPink Market under the symbol NTVA.